Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 BlockadeDouglas B. Johnson, Christine M. Lovly, Dennie T. Frederick et al.|Cancer Immunology Research|2016Cited by 493
<sup>Non-V600</sup><i>BRAF</i> Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal CancerJeremy Jones, Axel Grothey, Lindsay A. Renfro et al.|Journal of Clinical Oncology|2017Cited by 357
The distribution of <i><scp>BRAF</scp></i> gene fusions in solid tumors and response to targeted therapyJeffrey S. Ross, Philip J. Stephens|International Journal of Cancer|2015Cited by 346
Genetic hallmarks of recurrent/metastatic adenoid cystic carcinomaAllen S. Ho, Luc G.T. Morris, Angelica Ochoa et al.|Journal of Clinical Investigation|2019Cited by 210
Whole Cancer Genome Sequencing by Next-Generation MethodsJeffrey S. Ross, Maureen Cronin|American Journal of Clinical Pathology|2011Cited by 165